Genotech Corporation (XKON:066830)
South Korea · Delayed Price · Currency is KRW 1,097.00
+23.00 (2.14%)
At close: Feb 13, 2026
Genotech Market Cap
Genotech has a market cap or net worth of 6.14 billion as of February 13, 2026. Its market cap has decreased by -26.67% in one year.
Market Cap
6.14B
Enterprise Value
n/a
Revenue
7.28B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,097.00
Market Cap Chart
Since April 5, 2017, Genotech's market cap has decreased from 30.32B to 6.14B, a decrease of -79.74%. That is a compound annual growth rate of -16.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 6.14B | 0.09% |
| Dec 29, 2025 | 6.14B | -15.56% |
| Dec 30, 2024 | 7.27B | -31.58% |
| Dec 28, 2023 | 10.62B | -34.36% |
| Dec 29, 2022 | 16.18B | -23.65% |
| Dec 30, 2021 | 21.19B | 6.77% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |
| Epibiotech | 34.42B |
| ADBiotech | 32.47B |
| Moogene Medi | 19.98B |
| Plumbline Life Sciences | 18.93B |
| Femtobiomed | 12.34B |
| OLIPASS | 8.40B |